Gossamer Bio: PROSERA Phase 3 as a Nuanced, High-Probability Catalyst Supporting Buy Rating and Defined Downside
at www.tipranks.com (Tue, 10-Feb 6:35 AM)
Gossamer Bio (GOSS) Receives a Buy from Barclays
at www.tipranks.com (Tue, 10-Feb 2:56 AM)
